Granules Jeedimetla facility located at Hyderabad, Telangana, India has successfully completed the US FDA’s surveillance inspection with zero observations, the company announced through an exchange filing. The inspection was completed between June 19 and June 23.
Jeedimetla facility manufactures Active Pharmaceutical Ingredients (API) and Pharmaceutical Formulation Intermediates (PFIs).
Granules shares
The shares of Granules on Friday closed at Rs 286.95, down by 0.35 per cent.
Mumbai Horror: Concrete Slab Of Under-Construction Metro 4 Pillar Falls On Auto-Rickshaw & Car In Mulund West, 3-4 Injured; Terrifying Visuals Surface
'Ajit Pawar Was Discussing Merger With NCP (SP) Leaders,' Says Hasan Mushrif
Nagaland State Lottery Result: February 14, 2026, 1 PM Live - Watch Streaming Of Winners List Of Dear Narmada Sambad Morning Saturday Weekly Draw
Mom-To-Be Sonam Kapoor Glows In Pink Kalamkari Saree, Styles Baby Bump With Pistachio Baluchari Twist
